rs12986337

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_004924.6(ACTN4):​c.1977T>C​(p.Asn659Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.065 in 1,613,590 control chromosomes in the GnomAD database, including 3,757 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.057 ( 265 hom., cov: 32)
Exomes 𝑓: 0.066 ( 3492 hom. )

Consequence

ACTN4
NM_004924.6 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.00600

Publications

12 publications found
Variant links:
Genes affected
ACTN4 (HGNC:166): (actinin alpha 4) Alpha actinins belong to the spectrin gene superfamily which represents a diverse group of cytoskeletal proteins, including the alpha and beta spectrins and dystrophins. Alpha actinin is an actin-binding protein with multiple roles in different cell types. In nonmuscle cells, the cytoskeletal isoform is found along microfilament bundles and adherens-type junctions, where it is involved in binding actin to the membrane. In contrast, skeletal, cardiac, and smooth muscle isoforms are localized to the Z-disc and analogous dense bodies, where they help anchor the myofibrillar actin filaments. This gene encodes a nonmuscle, alpha actinin isoform which is concentrated in the cytoplasm, and thought to be involved in metastatic processes. Mutations in this gene have been associated with focal and segmental glomerulosclerosis. [provided by RefSeq, Jul 2008]
ACTN4 Gene-Disease associations (from GenCC):
  • focal segmental glomerulosclerosis 1
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • familial idiopathic steroid-resistant nephrotic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 19-38724532-T-C is Benign according to our data. Variant chr19-38724532-T-C is described in ClinVar as Benign. ClinVar VariationId is 259571.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.006 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0889 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ACTN4NM_004924.6 linkc.1977T>C p.Asn659Asn synonymous_variant Exon 16 of 21 ENST00000252699.7 NP_004915.2 O43707-1A0A0S2Z3G9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ACTN4ENST00000252699.7 linkc.1977T>C p.Asn659Asn synonymous_variant Exon 16 of 21 1 NM_004924.6 ENSP00000252699.2 O43707-1

Frequencies

GnomAD3 genomes
AF:
0.0572
AC:
8693
AN:
152084
Hom.:
266
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0502
Gnomad AMI
AF:
0.00658
Gnomad AMR
AF:
0.0617
Gnomad ASJ
AF:
0.0582
Gnomad EAS
AF:
0.0460
Gnomad SAS
AF:
0.0967
Gnomad FIN
AF:
0.0259
Gnomad MID
AF:
0.0759
Gnomad NFE
AF:
0.0638
Gnomad OTH
AF:
0.0578
GnomAD2 exomes
AF:
0.0635
AC:
15909
AN:
250450
AF XY:
0.0651
show subpopulations
Gnomad AFR exome
AF:
0.0509
Gnomad AMR exome
AF:
0.0698
Gnomad ASJ exome
AF:
0.0615
Gnomad EAS exome
AF:
0.0405
Gnomad FIN exome
AF:
0.0279
Gnomad NFE exome
AF:
0.0628
Gnomad OTH exome
AF:
0.0679
GnomAD4 exome
AF:
0.0659
AC:
96234
AN:
1461388
Hom.:
3492
Cov.:
38
AF XY:
0.0668
AC XY:
48593
AN XY:
727006
show subpopulations
African (AFR)
AF:
0.0518
AC:
1734
AN:
33472
American (AMR)
AF:
0.0729
AC:
3258
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.0632
AC:
1651
AN:
26128
East Asian (EAS)
AF:
0.0457
AC:
1815
AN:
39698
South Asian (SAS)
AF:
0.102
AC:
8761
AN:
86254
European-Finnish (FIN)
AF:
0.0305
AC:
1616
AN:
53016
Middle Eastern (MID)
AF:
0.0687
AC:
396
AN:
5766
European-Non Finnish (NFE)
AF:
0.0657
AC:
73010
AN:
1111952
Other (OTH)
AF:
0.0661
AC:
3993
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
6894
13789
20683
27578
34472
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2804
5608
8412
11216
14020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0571
AC:
8697
AN:
152202
Hom.:
265
Cov.:
32
AF XY:
0.0563
AC XY:
4194
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.0502
AC:
2083
AN:
41522
American (AMR)
AF:
0.0615
AC:
942
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.0582
AC:
202
AN:
3470
East Asian (EAS)
AF:
0.0461
AC:
239
AN:
5180
South Asian (SAS)
AF:
0.0961
AC:
464
AN:
4826
European-Finnish (FIN)
AF:
0.0259
AC:
274
AN:
10588
Middle Eastern (MID)
AF:
0.0748
AC:
22
AN:
294
European-Non Finnish (NFE)
AF:
0.0638
AC:
4341
AN:
67988
Other (OTH)
AF:
0.0587
AC:
124
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
451
902
1353
1804
2255
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
104
208
312
416
520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0595
Hom.:
116
Bravo
AF:
0.0594
Asia WGS
AF:
0.0890
AC:
311
AN:
3478
EpiCase
AF:
0.0649
EpiControl
AF:
0.0670

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 01, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Focal segmental glomerulosclerosis 1 Benign:2
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 12, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
6.1
DANN
Benign
0.61
PhyloP100
0.0060
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12986337; hg19: chr19-39215172; COSMIC: COSV53142966; COSMIC: COSV53142966; API